GlassScriptPhysician profile
Jesse W Tan
NPI 1285630202
$18,234.87
in general payments reported to CMS, 2019-2025
32 companies · $833 in 2025
The $833 reported for 2025 was more than what 75% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,790 · 2020: $6,735 · 2021: $1,885 · 2022: $2,921 · 2023: $1,338 · 2024: $1,733 · 2025: $833.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,938 · Travel and Lodging: $965.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,937.83 |
| Travel and Lodging | $965.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $5,013.70 | 2020-2022 | |
| Inspire Medical Systems, INC. | $2,962.03 | 2019-2023 | Inspire |
| Stryker Corporation | $2,382.12 | 2019-2025 | Xpress Ent Dilation System, Xpress Loprofile, Audion Et Dilation System |
| Intersect Ent, INC. | $1,667.56 | 2019-2022 | |
| Integra Lifesciences Corporation | $1,110.09 | 2024 | Inspira Air, Acclarent Aera, Trudi Probe |
| Genzyme Corporation | $924.47 | 2021-2025 | |
| Medical Device Business Services, INC. | $841.57 | 2020 | |
| Optinose US, INC. | $672.40 | 2019-2025 | |
| Glaxosmithkline, LLC. | $598.59 | 2021-2025 | Nucala |
| Regeneron Healthcare Solutions, INC. | $478.25 | 2021-2025 | Dupixent, Libtayo |
| Acclarent, INC | $378.00 | 2019-2020 | |
| Aerin Medical INC. | $333.59 | 2019-2025 | |
| Bard Access Systems, INC. | $223.08 | 2019 | |
| Ethicon US, LLC | $89.08 | 2020-2025 | Ligaclip, Harmonic, Surgicel Nu-Knit |
| Hikma Pharmaceuticals USA | $72.12 | 2022-2024 | Ryaltris |
Show all 32 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $54.34 | 2025 | Voquezna |
| Merck Sharp & Dohme LLC | $50.31 | 2023-2025 | Keytruda |
| Ambu INC. | $43.14 | 2020 | |
| Medtronic, INC. | $42.77 | 2025 | Pteye Parathyroid Detection System |
| Checkpoint Surgical, INC | $38.80 | 2019-2022 | |
| Baxter Healthcare | $32.09 | 2025 | Perclot |
| Hologic Sales and Service, LLC | $29.66 | 2024 | Coolseal Generator |
| Livanova USA, INC. | $29.09 | 2024 | Vns Therapy Sentiva Model 1000 Generator |
| Olympus America INC. | $26.37 | 2022 | |
| Eyevance Pharmaceuticals LLC | $20.54 | 2021 | |
| Covidien LP | $20.35 | 2019 | |
| Ironshore Pharmaceuticals INC. | $19.87 | 2019 | |
| Medtronic USA, INC. | $18.46 | 2020 | |
| Neurent Medical Limited | $17.15 | 2025 | Neuromark System, Neuromark Radiofrequency Console |
| Vertical Pharmaceuticals, LLC | $16.75 | 2024 | Dsuvia |
| Tactile Systems Technology INC | $15.47 | 2019 | |
| Smith+Nephew, INC. | $13.06 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Tan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.